EASI Score & Atopic Dermatitis Severity
The Eczema Area and Severity Index (EASI) quantifies atopic dermatitis severity across 4 body regions and 4 clinical signs. It guides treatment decisions and tracks response to therapy.
Did our AI summary help? Let us know.
EASI-75 is primary endpoint in biologic trials Score >21 indicates systemic therapy Maximum possible score is 72
Ready to run the numbers?
Why: EASI is the gold standard for measuring eczema severity in clinical trials and practice. It guides escalation from topical to systemic therapy.
How: Each body region is scored for erythema, edema, excoriation, and lichenification (0-3) plus area involved (0-6). Regional scores are weighted by body surface area.
Run the calculator when you are ready.
โ Clear/Minimal
Well-controlled eczema, minimal signs
Click to load
๐ Mild Eczema
Limited involvement, topical responsive
Click to load
โ ๏ธ Moderate Eczema
Broader involvement, consider escalation
Click to load
๐ด Severe Eczema
Extensive disease requiring systemic therapy
Click to load
๐จ Very Severe Eczema
Widespread, poorly controlled, urgent treatment needed
Click to load
๐ Biologic Candidate
Severe disease eligible for biologic therapy
Click to load
๐ถ Pediatric AD
Child with moderate atopic dermatitis
Click to load
Sample Patient Scenarios
โ Clear/Minimal
Well-controlled eczema, minimal signs
๐ Mild Eczema
Limited involvement, topical responsive
โ ๏ธ Moderate Eczema
Broader involvement, consider escalation
๐ด Severe Eczema
Extensive disease requiring systemic therapy
๐จ Very Severe Eczema
Widespread, poorly controlled, urgent treatment needed
๐ Biologic Candidate
Severe disease eligible for biologic therapy
๐ถ Pediatric AD
Child with moderate atopic dermatitis
Head and Neck (ร0.1)
Upper Extremities (ร0.2)
Trunk (ร0.3)
Lower Extremities (ร0.4)
Quality of Life & Symptoms
EASI Results
EASI: 9.9
Moderate
19%
BSA Affected
Head/Neck
Upper Limbs
Trunk
Lower Limbs
Biologic Eligible
EASI-50 Target
EASI-75 Target
EASI-90 Target
๐ Visual Analysis
Regional Scores
Score Distribution
Treatment Targets
Signs by Region
Detailed Analysis
| Total EASI Score | 9.9/72 |
| Severity Category | Moderate |
| Dominant Region | Lower Extremities |
| Dominant Sign | Erythema |
| Treatment Goal | Achieve EASI-75 response |
| Systemic Therapy Indicated | No |
| Suggested Retest | 8-12 weeks |
๐ Recommendations
Moderate eczema - consider treatment escalation if inadequate response
Atopic comorbidities present - consider systemic targeting
DLQI โฅ10 indicates very large effect on QoL - aggressive therapy warranted
๐งด Topical Therapy
Medium-to-high potency TCS
Proactive TCS therapy (weekend application)
๐ฟ Lifestyle Recommendations
Daily liberal emollient application
Lukewarm baths/showers, pat dry gently
Wear soft, breathable fabrics (cotton)
Identify and avoid personal triggers
Maintain humid environment (40-60% humidity)
Cool sleeping environment
Apply emollient before bed
๐ Monitoring Parameters
EASI score every 2-4 weeks during active treatment
DLQI or POEM for quality of life assessment
Itch NRS (0-10 scale)
Sleep quality assessment
Clinical Note: EASI is a clinician-assessed measure requiring direct skin examination. Treatment decisions should also consider patient-reported outcomes (DLQI, POEM), individual preferences, and comorbidities. Biologic eligibility criteria vary by region/payer.
For informational purposes only โ not medical advice. Consult a healthcare professional before acting on results.
๐ฅ Health Facts
EASI evaluates 4 signs: erythema, edema, excoriation, lichenification
โ Dermatology guidelines
EASI-75 response indicates 75% reduction from baseline
โ Clinical trials
Understanding EASI
The Eczema Area and Severity Index (EASI) is a validated clinician-assessed measure used to quantify the severity of atopic dermatitis. It evaluates 4 body regions for 4 signs of inflammation plus affected area.
4 Clinical Signs Assessed
- โข Erythema - Redness
- โข Edema/Papulation - Swelling
- โข Excoriation - Scratch marks
- โข Lichenification - Skin thickening
4 Body Regions
- โข Head/Neck (10% BSA) - ร0.1
- โข Upper Extremities (20% BSA) - ร0.2
- โข Trunk (30% BSA) - ร0.3
- โข Lower Extremities (40% BSA) - ร0.4
EASI Severity Categories
Treatment Response Endpoints
Related Calculators
SCORAD Calculator - Atopic Dermatitis Scoring
Calculate the SCORing Atopic Dermatitis (SCORAD) index to assess eczema severity. Evaluates disease extent, intensity, and subjective symptoms for...
HealthBraden Score Calculator
Predict pressure ulcer risk using the validated Braden Scale. Evaluates 6 subscales: sensory perception, moisture, activity, mobility, nutrition, and...
HealthA-a Gradient Calculator
Calculate the Alveolar-arterial (A-a) oxygen gradient to assess oxygenation efficiency. Helps differentiate between pulmonary and extrapulmonary causes of...
HealthAdvanced ABI Calculator (Ankle-Brachial Index)
Comprehensive Ankle-Brachial Index calculator with multiple measurement methods, advanced PAD risk assessment, exercise testing capability, cardiovascular...
HealthABSI Calculator (A Body Shape Index)
Calculate your A Body Shape Index (ABSI) to assess health risks and mortality prediction based on waist circumference, height, and weight. Get personalized...
HealthAbsolute Eosinophil Count (AEC) Calculator
Calculate Absolute Eosinophil Count from CBC with differential. Assess eosinophilia severity, identify potential allergic, parasitic, or autoimmune...
Health